Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof

MYPI2025005929A0Undetermined Publication Date: 2021-07-29GENZYME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005929
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-01-29
Filing Date
2021-01-29
Publication Date
2021-07-29
Patent Text Reader

Abstract

Provided herein are modified adeno-associated viral (AAV) capsid proteins, compositions (e.g., rAAV) comprising the capsid proteins, and nucleic acids encoding the capsid proteins. The AAV capsids provided herein confer retinal cell tropism and / or corneal cell tropism, and mediate improved transduction efficiency in clinically relevant ocular cell types such as photoreceptors and / or corneal endothelial cells. Also provided are nucleic acids encoding the capsid proteins, and AAV particles comprising the capsid proteins.
Need to check novelty before this filing date? Find Prior Art